We Power Antibody Discovery

  • Adagene Raises $50 Million in Series C Funding

  • Adagene and WuXi Biologics Announce Strategic Development and Manufacturing Partnership

QUALITY BY DESIGN
Read more

BEYOND MOTHER NATURE
Read more
ABOUT ADAGENE

Adagene’s headquarters are in the historic city of Suzhou, China, home to the UNESCO World Heritage Classical Gardens of Suzhou. These gardens date back a millennia, and echo a central premise upon which Adagene is founded, the balance between human ingenuity and mother nature.
We are proud to continue this tradition of balance between human engineering and natural properties in our antibody design as we strive to cure disease.

Suzhou.China
NEWS
Adagene Raises $50 Million in Series C Funding

SUZHOU, China, March. 26, 2018 /PRNewswire/ -- Adagene Inc., a leading antibody discovery and development company, today announced a $50 million Series C financing, led by Sequoia China, and backed by New World TMT, AVIC Trust, King Star Capital, Gopher Asset Management as well as other investors. The round was oversubscribed.

2018.03.26
©Copyright-Adagene 2018